Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making

Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making

US Patent 11911483 · Granted Feb 27, 2024

Estimated economic value: $121,878,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists2025
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists2025
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists a2023
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists a2023
Macrocyclic toll-like receptor 7 (TLR7) agonists2022
Macrocyclic toll-like receptor 7 (TLR7) agonists2022
2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists a2022
2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists a2022
Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acet2021
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates there2021
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates there2021
Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates t2021